SoFi shares rise as record revenue, member growth drive strong Q3 results
LONDON - Inspiration Healthcare Group plc (AIM:IHC) reported a 41% increase in revenue to £24.0 million for the six months ended July 31, 2025, compared to £17.0 million in the same period last year, according to a press release issued Tuesday.
The medical technology company’s growth was primarily driven by neonatal product sales and the execution of two major export contracts—one in the Middle East and another with UNICEF—which the company described as the largest in its history.
Gross profit rose to £11.1 million from £7.4 million a year earlier, with gross margin improving to 46.2% from 43.5%. The company attributed the margin improvement to higher capital sales and a favorable neonatal product mix.
Inspiration Healthcare reported an adjusted EBITDA profit of £1.3 million, reversing a loss of £0.9 million in the first half of fiscal 2025. Operating profit was £0.2 million, compared to a loss of £3.2 million in the prior-year period.
The company generated £3.6 million in cash from operating activities, a significant improvement from the £2.3 million cash outflow reported a year earlier. This performance was supported by the EBITDA profit, reduced working capital (particularly inventories), and receipt of £0.7 million in R&D tax credits.
Net debt, excluding IFRS16 lease liabilities, decreased to £6.7 million from £8.3 million as of January 31, 2025.
The company also reported progress on its U.S. market entry plans for its SLE6000 ventilator, with testing underway for FDA submission in the second half of 2026 and a planned launch in the first half of 2027.
Inspiration Healthcare stated that operational improvements are driving underlying growth in neonatal products, independent of the one-off export orders.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.